Vitamin e inhibits oxidative stress-induced denaturation of nerve terminal proteins involved in neurotransmission

Journal of Alzheimer's Disease

Volumn 28, Issue 1, 2012, Pages 183-189

  Kaneai, Nozomi ^a   Arai, Masaya ^a   Takatsu, Hirokatsu ^a   Fukui, Koji ^a   Urano, Shiro ^a  

^a SHIBAURA INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Neurotransmission; oxidative stress; SNARE protein; synaptic membrane fusion; vitamin E

Indexed keywords

ALPHA TOCOPHEROL; REACTIVE OXYGEN METABOLITE; SNARE PROTEIN; SYNAPTOBREVIN; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; SYNAPTOTAGMIN; SYNTAXIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; IMMUNOBLOTTING; NERVE ENDING; NEUROTRANSMISSION; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DENATURATION; PROTEIN EXPRESSION; RAT; SYNAPSE VESICLE; SYNAPTIC MEMBRANE; VITAMIN SUPPLEMENTATION;

EID: 84855763142     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-111133     Document Type: Article

References (27)

1. Katzman R (1986) Alzheimers disease. N Engl J Med 314, 964-973.
2. Keller JN, Schmitt FA, Scheff SW, Ding Q, Chen Q, Butterfield DA, Markesbey WR (2005) Evidence of increased oxidative damage in subject with mild cognitive impairment. Neurology 64, 1152-1156.
3. Butterfield DA, Perluigi M, Sultana S (2006) Oxidative stress in Alzheimers disease brain: New insights from redox proteomics. Eur J Pharmacol 545, 39-50. (Pubitemid 44215876)
4. Halliwell B (1989) Oxidants and the central nervous system: Some fundamental questions. Acta Neurol Scand 126, 23-33.
5. Onodera K, Omoi N, Fukui K, Hayasaka T, Shinkai T, Suzuki S, Abe K, Urano S (2003) Oxidative damage of rat cerebral cortex and hippocampus, and changes in antioxidative defense systems caused by hyperoxia. Free Radic Res 37, 367-372. (Pubitemid 36240399)
6. Nishio T, Miyadera R, Sakai R, Abe K, Kanazawa H, Fukui K, Urano S (2006) Increased F2-isoprostane levels in the rat brain and plasma caused by oxidative stress and aging, and inhibitory effect of vitamin E. J Clin Biochem Nutr 38, 161-166. (Pubitemid 43761951)
7. Urano S, Asai Y, Makabe S, Matsuo M, Izumiyama N, Ohtsubo K, Endo T (1997) Oxidative injury of synapse and alteration of antioxidative defense systems in rats, and its prevention by vitamin E, Eur J Biochem 245, 64-70. (Pubitemid 27142264)
8. Fukui K, Omoi N, Hayasaka T, Shinkai T, Suzuki S, Abe K, Urano S (2002) Cognitive impairment of rats caused by oxidative stress and aging, and its prevention by vitamin E. Ann N Y Acad Sci 959, 275-284. (Pubitemid 34457568)
9. Fukui K, Takatsu K, Shinkai T, Suzuki S, Abe K, Urano S (2005) Appearance of amyloid β-like substances and delayedtype apoptosis in rat hippocampus CA1 region through aging and oxidative stress. J Alzheimers Dis 8, 299-309.
10. Urano S, Sato Y, Otonari T, Makabe S, Suzuki S, Ogata M, Endo T (1999) Aging and oxidative stress in neurodegeneration. BioFactor 7, 103-112. (Pubitemid 28073880)
11. Arai M, Saito M, Takatsu H, Fukui K, Urano S (2011) Dysfunction of the fusion of pre-synaptic plasma membranes and synaptic vesicles caused by oxidative stress, and its prevention by vitamin E. J Alzheimers Dis 24, 759-766.
12. Lin RC, Scheller RH (1997) Structural organization of the synaptic exocytosis core complex. Neuron 19, 1087-1094. (Pubitemid 27512368)
13. Söllner T, Whiteheart SW, Brunner M, Erdjument-Bromage H, Geromanos S, Tempst P, Rothmann JE (1993)SNAPreceptors implicated in the vesicle targeting and fusion. Nature 362, 318-324. (Pubitemid 23101303)
14. Rothmann JE, Warren G (1994) Implications of the SNARE hyposis for intracellular membrane topology and dynamics. Curr Biol 4, 220-233.
15. Südhof TC (1995) The synaptic vesicle cycle: A cascade of protein-protein interactions. Nature 362, 645-653.
16. Masliah E, Terry RD, DeTeresa RM, Hansen LA (1989) Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease. Neurosci Lett 103, 234-239. (Pubitemid 19201259)
17. Masliah E, Terry RD, Alford M, DeTeresa RM, Hansen LA (1991) Cortical and subcortical patterns of synaptophysin-like immunoreactivity in Alzheimers disease. Am J Pathol 138, 235-246.
18. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa RM, Hill R, Hansen LA, Katzman R (1991) Physical basis of cognitive alterations in Alzheimers disease: Synapse loss is the major correlate of cognitive impairment. Ann Neurol 30, 572-580.
19. Shimohama S, Kamiya S, Taniguchi T, Akagawa K, Kimura J (1997) Differential involvement of synaptic vesicle and presynaptic plasma membrane proteins in Alzheimers disease. Biochem Biophys Res Commun 236, 239-242. (Pubitemid 27373275)
20. Zhu X, Smith MA, Honda K, Aliev G, Moreira PI, Nunomura A, Casadesus G, Harris PL, Siedlak SL, Perry G (2007) Vascular oxidative stress in Alzheimers disease. J Neurol Sci 257, 240-246. (Pubitemid 46856513)
21. Dodd PR, Hardy JR, Oakley AE, Edwardson JA, Perry EK, Delaunoy JP (1981) A rapid method for preparing synaptosomes: Comparison with alternative procedures. Brain Res 226, 107-118. (Pubitemid 12193709)
22. Omoi N, Arai M, Saito M, Takatsu H, Shibata A, Fukuzawa K, Sato K, Abe K, Fukui K, Urano S (2006) Influence of oxidative stress on fusion of pre-synaptic plasma membranes of the rat brain with phosphatidyl choline liposomes, and protective effect of vitamin E. J Nutr Sci Vitaminol 52, 248-255. (Pubitemid 44520052)
23. Shimahama S, Fujimoto S, Sumida Y, Akagawa K, Shirao T, MatsuokaY, Taniguchi T (1998) Differential expression of rat brain synaptic proteins in development and aging. Biochem Biophys Res Commun 251, 394-398. (Pubitemid 28498122)
24. Azzi A, Stocker A (2000) Vitamin E: Non-antioxidant roles. Prog Lipid Res 39, 231-255. (Pubitemid 30224705)
25. Galli F, Azzi A (2010) Present trends in vitamin E research. Biofactors 36, 33-42.
26. Sen CK, Khanna S, Roy S, Packer L (2000) Molecular basis of vitamin E action. J Biol Chem 275, 13049-13055.
27. Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Cotman CW, Pfeiffer E, Schneider LS, Thal LJ (1997) A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimers disease. The Alzheimers disease cooperative study. New Engl J Med 336, 1216-1222. (Pubitemid 27183651)